Taiwan · Delayed Price · Currency is TWD Feng Chi Biotech Statistics
Total Valuation
TPEX:6744 has a market cap or net worth of TWD 215.60 million. The enterprise value is 47.79 million.
| Market Cap | 215.60M |
| Enterprise Value | 47.79M |
Important Dates
The next estimated earnings date is Wednesday, August 19, 2026.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | Jul 21, 2026 |
Share Statistics
TPEX:6744 has 15.40 million shares outstanding. The number of shares has decreased by -1.05% in one year.
| Current Share Class | 15.40M |
| Shares Outstanding | 15.40M |
| Shares Change (YoY) | -1.05% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 14.35% |
| Owned by Institutions (%) | n/a |
| Float | 5.20M |
Valuation Ratios
The trailing PE ratio is 21.59.
| PE Ratio | 21.59 |
| Forward PE | n/a |
| PS Ratio | 1.37 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | 125.20 |
| P/OCF Ratio | 89.09 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.43, with an EV/FCF ratio of 27.75.
| EV / Earnings | 4.82 |
| EV / Sales | 0.30 |
| EV / EBITDA | 2.43 |
| EV / EBIT | 6.69 |
| EV / FCF | 27.75 |
Financial Position
The company has a current ratio of 4.48, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.48 |
| Quick Ratio | 3.84 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.21 |
| Debt / FCF | 2.35 |
| Interest Coverage | 49.58 |
Financial Efficiency
Return on equity (ROE) is 4.28% and return on invested capital (ROIC) is 10.15%.
| Return on Equity (ROE) | 4.28% |
| Return on Assets (ROA) | 1.52% |
| Return on Invested Capital (ROIC) | 10.15% |
| Return on Capital Employed (ROCE) | 3.09% |
| Weighted Average Cost of Capital (WACC) | 5.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 32 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.79 |
Taxes
In the past 12 months, TPEX:6744 has paid 1.39 million in taxes.
| Income Tax | 1.39M |
| Effective Tax Rate | 12.32% |
Stock Price Statistics
The stock price has decreased by -22.22% in the last 52 weeks. The beta is 0.30, so TPEX:6744's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -22.22% |
| 50-Day Moving Average | 15.39 |
| 200-Day Moving Average | 17.14 |
| Relative Strength Index (RSI) | 36.83 |
| Average Volume (20 Days) | 39,369 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6744 had revenue of TWD 156.99 million and earned 9.91 million in profits. Earnings per share was 0.65.
| Revenue | 156.99M |
| Gross Profit | 70.45M |
| Operating Income | 7.14M |
| Pretax Income | 11.30M |
| Net Income | 9.91M |
| EBITDA | 16.98M |
| EBIT | 7.14M |
| Earnings Per Share (EPS) | 0.65 |
Balance Sheet
The company has 171.85 million in cash and 4.04 million in debt, with a net cash position of 167.81 million or 10.90 per share.
| Cash & Cash Equivalents | 171.85M |
| Total Debt | 4.04M |
| Net Cash | 167.81M |
| Net Cash Per Share | 10.90 |
| Equity (Book Value) | 229.51M |
| Book Value Per Share | 15.05 |
| Working Capital | 174.67M |
Cash Flow
In the last 12 months, operating cash flow was 2.42 million and capital expenditures -698,000, giving a free cash flow of 1.72 million.
| Operating Cash Flow | 2.42M |
| Capital Expenditures | -698,000 |
| Depreciation & Amortization | 9.85M |
| Net Borrowing | -2.76M |
| Free Cash Flow | 1.72M |
| FCF Per Share | 0.11 |
Margins
Gross margin is 44.87%, with operating and profit margins of 4.55% and 6.31%.
| Gross Margin | 44.87% |
| Operating Margin | 4.55% |
| Pretax Margin | 7.20% |
| Profit Margin | 6.31% |
| EBITDA Margin | 10.82% |
| EBIT Margin | 4.55% |
| FCF Margin | 1.10% |
Dividends & Yields
This stock pays an annual dividend of 0.95, which amounts to a dividend yield of 6.79%.
| Dividend Per Share | 0.95 |
| Dividend Yield | 6.79% |
| Dividend Growth (YoY) | -11.58% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 147.70% |
| Buyback Yield | 1.05% |
| Shareholder Yield | 7.84% |
| Earnings Yield | 4.59% |
| FCF Yield | 0.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |